Effects of Alcohol on Simulated Driving
- Registration Number
- NCT00477984
- Lead Sponsor
- Utrecht Institute for Pharmaceutical Sciences
- Brief Summary
Previous studies have shown that alcohol significantly impairs driving performance. Acute alcohol administration also has a detrimental effect on secondary task performance during dual-tasks. The present study will investigate the effects of five different dosages of ethanol (0,0.2, 0,5, 0,8 and 1,0 % BAC) on performance in a driving simulator. Steering performance and brain activity will be recorded in both single- and dual-task conditions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- He/she is aged between 21-50
- Written informed consent
- Right-handed
- Normal static binocular acuity, corrected or uncorrected
- Normal hearing
- Social Drinker (average of 7 to 21 alcoholic drinks per week)
- Possession of a drivers license
- Be considered as reliable and mentally capable of adhering to the protocol.
- Current drug use (positive urine drug screen on the presence of amphetamines (including MDMA), barbiturates, cannabinoids, benzodiazepines, cocaine, and opiates)
- Positive urine pregnancy drug screen in women
- Use of psychoactive medication
- Positive alcohol breath test
- Prior enrolment in the same study
- Physical or mental illness
- Excessive alcohol use (>21 alcoholic drinks per week)
- Excessive smoking (more than 10 cigarettes per day)
- Intake of caffeine-containing beverages over 5 glasses per day
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description A alcohol alcohol and placebo
- Primary Outcome Measures
Name Time Method Primary parameter of the steering simulator is the standard deviation of the car from the center of the road (steering error). 5 testdays
- Secondary Outcome Measures
Name Time Method Reaction speed after hearing the deviant target tone. Brain activity: ERPs of interest are the mismatch negativity (MMN), P3a, P3b, and reorienting negativity (RON) 5 testdays
Trial Locations
- Locations (1)
Utrecht Institute for Pharmaceutical Sciences
🇳🇱Utrecht, Netherlands